SHANGHAI, March 13, 2026 /PRNewswire/ — Aphranel, a China-origin regenerative medical aesthetics brand under the company SHANGHAI MOYANG BIOTECHNOLOGY, has…
Read More
SHANGHAI, March 12, 2026 /PRNewswire/ — Aphranel, a China-origin regenerative medical aesthetics brand under the company SHANGHAI MOYANG BIOTECHNOLOGY, has…
Read More
SINGAPORE, March 12, 2026 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization…
Read More